Organization
Mustafa Khasraw
4 clinical trials
Clinical trial
I-ATTAC: Improved Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated GliomaStatus: Terminated, Estimated PCD: 2023-02-10
Clinical trial
A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain MetastasesStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Clinical trial
ETAPA I: Evaluation of Tumor Associated P30-Peptide Antigen I; A Pilot Trial of Peptide-based Tumor Associated Antigen Vaccines in Newly Diagnosed, Unmethylated, and Untreated Glioblastoma (GBM)Status: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Evaluation of Overcoming Limited Migration and Enhancing Cytomegalovirus-specific Dendritic Cell Vaccines With Adjuvant TEtanus Pre-conditioning in Patients With Newly-diagnosed GlioblastomaStatus: Completed, Estimated PCD: 2020-10-31